Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41
Open Access
- 1 May 2008
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 134 (5) , 1385-1395.e1
- https://doi.org/10.1053/j.gastro.2008.02.058
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infectionJournal of Viral Hepatitis, 2007
- Absence of viral escape within a frequently recognized HLA-A26-restricted CD8+ T-cell epitope targeting the functionally constrained hepatitis C virus NS5A/5B cleavage siteJournal of General Virology, 2007
- Treating viral hepatitis C: efficacy, side effects, and complicationsGut, 2006
- Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjectsVaccine, 2006
- Comprehensive Analyses of CD8+ T Cell Responses During Longitudinal Study of Acute Human Hepatitis C *Hepatology, 2005
- Regulatory T Cells Suppress In Vitro Proliferation of Virus-Specific CD8+T Cells during Persistent Hepatitis C Virus InfectionJournal of Virology, 2005
- Mutational escape from CD8+ T cell immunityThe Journal of Experimental Medicine, 2005
- Immunology of hepatitis B virus and hepatitis C virus infectionNature Reviews Immunology, 2005
- Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infectionHepatology, 2003
- Novel Cd4+ and Cd8+ T–Cell Determinants Within the Ns3 Protein in Subjects With Spontaneously Resolved Hcv InfectionHepatology, 2003